When was Darmiyan founded?

Darmiyan was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is Darmiyan located?

Darmiyan is headquartered in San Francisco, United States.

Who is the current CEO of Darmiyan?

Padideh Kamali-Zare of Darmiyan.

How many employees does Darmiyan have?

As of Aug 31, 2026, the latest employee count at Darmiyan is 23.

Is Darmiyan a funded company?

Darmiyan is a funded company, having raised a total of $10.1M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2017.

How much is Darmiyan worth?

The latest valuation of Darmiyan is $***** as of Jan 01, 2017. This marks a decline of 1% from its peak valuation of $1.71M in Jan, 2017. This marks a decline of 1% from its peak valuation of $1.71M in Jan, 2017.

When was the latest funding round of Darmiyan?

Darmiyan's latest funding was a $***** Seed round on Oct 17, 2023, with participation from 0 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $6.41B in funding in 2026 to date.

Where does Darmiyan rank among its competitors?

Darmiyan ranks 3rd amongst 189 active competitors, of which 28 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Imaginostics, which secured $40K in May, 2026.

Who are the top competitors of Darmiyan?

Darmiyan's top competitors include Nudge, VISIE and Panaxium. Among them, Imaginostics secured the most recent funding round in May, 2026.

Darmiyan - 2026 Company Profile, Team, Funding & Competitors

Darmiyan is a seed company based in San Francisco (United States), founded in 2015 by Padideh Kamali-Zare, Thomas Liebmann and Kaveh Vejdani. It operates as a Platform for presymptomatic diagnosis of neurodegenerative disorders. Darmiyan has raised $10.1M in funding from Eisai Innovation, with a current valuation of $*****. The company has 189 active competitors, including 28 funded and 7 that have exited. Its top competitors include companies like Nudge, VISIE and Panaxium.

Company Details

Darmiyan provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of abnormality in the brain. It generates dynamic maps of distribution kinetics in the brain and can be used for novel drugs and biomolecules discovery and testing. The imaging solution allows users to identify areas of neuro degeneration and can be helpful for MRI image analysis.

Website: darmiyan.com
Social
Email ID: *****@darmiyan.com

Key Metrics

Founded Year

2015

Location

San Francisco, United States

Stage

Seed

Total Funding

$10.1M in 3 rounds

Latest Funding Round

Seed, Oct 17, 2023, $*****

Post Money Valuation

$***** as on Jan 01, 2017

Investors

Eisai Innovation & 12 more

Ranked

3^rd among 189 active competitors

Employee Count

23 as on Aug 31, 2026

Similar Companies

Nudge & 223 more

View Darmiyan's full profile

Darmiyan is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Darmiyan, Inc. CIN: 814163400 , United States, Active	Apr 05, 2020	-	-	-

Darmiyan has raised a total funding of $10.1M over 3 rounds. Its first funding round was on 2017. Darmiyan has 13 institutional investors.

Here is the list of recent funding rounds of Darmiyan:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 17, 2023	1076292	Seed	3772373	5512747	2985924	6855127
Apr 06, 2020	6189341	Seed	4221973	2470121	5704261	Y Combinator & 1 more
2017	7053	Seed	8305	6941	7596	Y Combinator

Access funding benchmarks and valuations. Sign up today!

View details of Darmiyan's funding rounds and investors

The founders of Darmiyan are Padideh Kamali-Zare, Thomas Liebmann and Kaveh Vejdani.

Here are the details of Darmiyan's key team members:

Padideh Kamali-Zare: Co-Founder & CEO of Darmiyan.
Contact Info: 1 email address
Thomas Liebmann: Co-Founder & CSO of Darmiyan.
Contact Info: 1 email address
Kaveh Vejdani: Co-Founder & CTO of Darmiyan.
Contact Info: 1 email address

View details of Darmiyan's Founder profiles and Board Members

Darmiyan's employee count trend

Darmiyan has 23 employees as of Aug 26. Here is Darmiyan's employee count trend over the years:

Uncover Darmiyan's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Darmiyan include Nudge, VISIE and Panaxium. Here is the list of Top 10 competitors of Darmiyan, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nudge 2024, San Francisco (United States), Series A	Developer of whole-brain interfaces intended to improve human-brain interaction	$100M	Thrive Capital, Greenoaks	55/100
2nd	VISIE 2017, Austin (United States), Series A	Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery	$12.7M	Capital Factory, Flat Rock Global & 7 others	54/100
3rd	Darmiyan 2015, San Francisco (United States), Seed	Platform for presymptomatic diagnosis of neurodegenerative disorders	$10.1M	Pegasus Tech Ventures, DHVC & 11 others	53/100
4th	Panaxium 2016, Aix-en-Provence (France), Seed	Developer of medical equipment for surgeons and neurologists to treat brain injuries	-	Ontario Brain Institute, Europa & 1 others	53/100
5th	SecondWave Systems 2019, Minneapolis (United States), Series A	Digital medical imaging solution for healthcare professionals	$7M	Treo Ventures, Sectoral & 4 others	53/100
6th	Inscopix 2011, Palo Alto (United States), Acquired	Platform specialized in developing miniscope platforms for decoding brain neural circuits	$11.5M	Playground Global, AME Cloud Ventures & 2 others	52/100
7th	Imaginostics 2011, Cambridge (United States), Series A	Provider of solution for magnetic resonance imaging biomarkers for diagnosis of neurological disorder	$7.64M	Ideaship, HHS & 2 others	51/100
8th	INFINITT Healthcare 2002, Seoul (South Korea), Public	Developer of medical imaging technologies	-	-	48/100
9th	IMEXHS 2012, Mascot (Australia), Public	Provider of software for image based diagnosis of diseases	-	x10 Partners	47/100
10th	Nurea 2018, Bordeaux (France), Funding Raised	Provider of image-based diagnostic software for doctors	-	Paris Business Angels, Europa & 1 others	46/100